Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first‐in‐human study and during experimental human endotoxaemia in healthy subjects
Christopher Geven(Radboud University Nijmegen), Peter Pickkers(Radboud University Nijmegen), Dirk van Lier(Radboud University Nijmegen), Alice Blet(Inserm), Matthijs Kox(Radboud University Medical Center), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Bas ten Elzen(Radboud University Nijmegen), Roel V. Peelen(Radboud University Nijmegen)
Cited by 44
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k